Alpha 2.0
Login Register
» Authors » W D Travis

W D Travis

Explore the profile of W D Travis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 195
Citations 5805
Followers 0
Related Specialties
Pathology
Oncology
Pulmonary Medicine
Top 10 Co-Authors
T V Colby
M N Koss
V J Ferrans
M V Fleming
D G Guinee Jr
L A Liotta
J Moss
K Matsui
H I Pass
S A Rosenberg
Published In
Am J Surg Pathol
Arch Pathol Lab Med
Hum Pathol
Cancer
Am J Clin Pathol
Affiliations
Soon will be listed here.
Recent Articles
1.
National vs. State Quarantine
Travis W
Atlanta Med Surg J (1884) . 2022 Jul; 15(1):10-13. PMID: 35828139
No abstract available.
2.
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
Schoenfeld A, Rizvi H, Bandlamudi C, Sauter J, Travis W, Rekhtman N, et al.
Ann Oncol . 2020 Mar; 31(5):599-608. PMID: 32178965
Background: Programmed death-ligand 1 (PD-L1) expression is the only FDA-approved biomarker for immune checkpoint inhibitors (ICIs) in patients with lung adenocarcinoma, but sensitivity is modest. Understanding the impact of molecular...
3.
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center
Galateau Salle F, Le Stang N, Nicholson A, Pissaloux D, Churg A, Klebe S, et al.
J Thorac Oncol . 2018 May; 13(8):1189-1203. PMID: 29723687
Introduction: The 2015 WHO classification of tumors categorized malignant mesothelioma into epithelioid, biphasic (BMM), and sarcomatoid (SMM) for prognostic relevance and treatment decisions. The survival of BMM is suspected to...
4.
Common and uncommon manifestations of wegener's granulomatosis
Travis W
Cardiovasc Pathol . 2015 May; 3(3):217-25. PMID: 25990999
No abstract available.
5.
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
Caplin M, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, et al.
Ann Oncol . 2015 Feb; 26(8):1604-20. PMID: 25646366
Background: Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity of randomized studies, this expert consensus document represents an initiative by the European Neuroendocrine Tumor Society to provide...
6.
The 2015 WHO classification of lung tumors
Travis W
Pathologe . 2014 Nov; 35 Suppl 2:188. PMID: 25394966
No abstract available.
7.
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
Van Schil P, Asamura H, Rusch V, Mitsudomi T, Tsuboi M, Brambilla E, et al.
Eur Respir J . 2011 Aug; 39(2):478-86. PMID: 21828029
A new adenocarcinoma classification was recently introduced by a joint working group of the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory...
8.
Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification
Travis W, Brambilla E, Van Schil P, Scagliotti G, Huber R, Sculier J, et al.
Eur Respir J . 2011 Aug; 38(2):239-43. PMID: 21804158
No abstract available.
9.
Advances in neuroendocrine lung tumors
Travis W
Ann Oncol . 2010 Oct; 21 Suppl 7:vii65-71. PMID: 20943645
Pulmonary neuroendocrine (NE) tumors include a spectrum of tumors from the low-grade typical carcinoid (TC) and intermediate-grade atypical carcinoid (AC) to the high-grade large-cell neuroendocrine carcinoma (LCNEC) and small-cell carcinoma...
10.
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Han M, Murray S, Fell C, Flaherty K, Toews G, Myers J, et al.
Eur Respir J . 2008 Mar; 31(6):1183-8. PMID: 18321929
In idiopathic pulmonary fibrosis, incidence is higher in males, and females may have better survival. The aim of the present study was to determine whether the rate of increase in...